Stay updated on Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a version update from v3.3.3 to v3.3.4 with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a consolidated Locations section with expanded study sites across multiple US states and other countries, and removed the previous per-state location entries (and the HHS Vulnerability Disclosure link) to streamline navigation.SummaryDifference1%

- Check60 days agoChange DetectedAdded an explanatory note that publications are automatically filled in from PubMed and included the revision label 'v3.3.2'; the prior PubMed-related wording and the older revision 'v3.2.0' have been removed.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the government funding lapse banner, which did not affect core study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedThe screenshots show only minor layout and formatting adjustments; the core study data (title, NCT03657043, conditions, eligibility criteria, outcomes, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check103 days agoChange DetectedAdded a Publications section citing a new PubMed article (new core content and proper nouns) with a full bibliographic reference; no deletions present.SummaryDifference2%

Stay in the know with updates to Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.